2nd Gene Therapy for Ophthalmic Disorders
Evvnt Promotion / evvnt
Archivio
21.09.2021 - 23.09.2021 Online
Time: 8:00 am - 5:00 pm
Temi della conferenza
Returning in September as a digital event, the 2nd Gene Therapy for Ophthalmic Disorders meeting will target the industry’s translational challenges in targeting both rare and common ophthalmic disorders including wet AMD, dry AMD, DME, IRDs and more.
Discover novel vectors and administration routes for optimal retinal delivery with 30+ world class speakers from the likes of GenSight Biologics, Biogen, Gyroscope Therapeutics, Novartis, Horama and REGENXBIO.
Returning in September as a digital event, the 2nd Gene Therapy for Ophthalmic Disorders meeting will target the industry’s translational challenges in targeting both rare and common ophthalmic disorders including wet AMD, dry AMD, DME, IRDs and more.
Discover novel vectors and administration routes for optimal retinal delivery with 30+ world class speakers from the likes of GenSight Biologics, Biogen, Gyroscope Therapeutics, Novartis, Horama and REGENXBIO.
Scientific organizer
Hanson Wade
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/780504-0?pid=4832
Speakers: Nicolas Ferry, Chief Development Officer, HORAMA, Rei Nakamura, Clinical Country Lead, Biogen and more
Brochure: https://go.evvnt.com/780504-0?pid=4832
Speakers: Nicolas Ferry, Chief Development Officer, HORAMA, Rei Nakamura, Clinical Country Lead, Biogen and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/780504-1?pid=4832
Ms. Ellie Saunders
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
